This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Deguang Liang: Innovator in Cancer Research
Introduction
Deguang Liang is a prominent inventor based in New York, NY (US). He is known for his significant contributions to cancer research, particularly through his innovative work at the Memorial Sloan Kettering Cancer Center. His research focuses on developing small molecule inhibitors that target specific cancer pathways.
Latest Patents
Deguang Liang holds a patent for "Small Molecule Inhibitors of ULK1." This patent represents a crucial advancement in the field of cancer treatment, as it explores new avenues for inhibiting cancer cell growth.
Career Highlights
Throughout his career, Deguang Liang has made notable strides in cancer research. His work at the Memorial Sloan Kettering Cancer Center has positioned him as a key figure in the development of novel therapeutic strategies. He has been instrumental in advancing our understanding of cancer biology and treatment.
Collaborations
Deguang Liang has collaborated with esteemed colleagues, including Pui-Mun Wong and Xuejun Jiang. These partnerships have fostered a collaborative environment that enhances the research output and innovation at the center.
Conclusion
Deguang Liang's contributions to cancer research through his patent and collaborative efforts highlight his commitment to advancing medical science. His work continues to inspire future innovations in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile